SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sandu Pharmaceuticals informs about compliances-certificate

07 Oct 2025 Evaluate
In compliance with Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018, Sandu Pharmaceuticals has forwarded a copy of certificate received from MUFG Intime India, the Registrar and Share Transfer Agents of the Company for the Quarter ended 30th September 2025. 

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

42.39 -0.51 (-1.19%)
18-Jun-2026 14:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.70
Dr. Reddys Lab 1265.60
Cipla 1352.75
Zydus Lifesciences 1072.95
Lupin 2325.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: